DS Biopharma 
Welcome,         Profile    Billing    Logout  
 2 Products   0 Diseases  2 Products   1 Trial   38 News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
daleuton oral (DS107 oral) / DS Biopharma
2017-004098-15: A Randomised, Double-blind, Placebo-controlled, Phase 2 Study to Assessthe Efficacy and Safety of Orally Administered DS107 in a once daily doseof 2g in Haemodialysis Patients with Moderate to Severe Uremic Pruritus

Ongoing
2
110
Europe
Dihomo-Gamma-Linolenic Acid, DGLA, DS107G, Capsule, soft
DS Biopharma, DS Biopharma
Moderate to Severe Uremic Pruritus, Moderate to Severe Uremic Pruritus, Diseases [C] - Skin and Connective Tissue Diseases [C17]
 
 
2019-000932-25: Study to Assess the Efficacy and Safety of Orally Administered DS107 in Adult Patients with Moderate to Severe Atopic Dermatitis

Not yet recruiting
2
220
Europe
DS107 Capsule, DS107G, Capsule, soft
DS Biopharma Ltd., DS Biopharma Ltd.
Moderate to Severe Atopic Dermatitis, Moderate to Severe Atopic Dermatitis, Diseases [C] - Skin and Connective Tissue Diseases [C17]
 
 
Galepa (daleuton topical) / DS Biopharma
No trials found
DS109 oral / DS Biopharma
No trials found
DS109 topical / DS Biopharma
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
daleuton oral (DS107 oral) / DS Biopharma
2017-004098-15: A Randomised, Double-blind, Placebo-controlled, Phase 2 Study to Assessthe Efficacy and Safety of Orally Administered DS107 in a once daily doseof 2g in Haemodialysis Patients with Moderate to Severe Uremic Pruritus

Ongoing
2
110
Europe
Dihomo-Gamma-Linolenic Acid, DGLA, DS107G, Capsule, soft
DS Biopharma, DS Biopharma
Moderate to Severe Uremic Pruritus, Moderate to Severe Uremic Pruritus, Diseases [C] - Skin and Connective Tissue Diseases [C17]
 
 
2019-000932-25: Study to Assess the Efficacy and Safety of Orally Administered DS107 in Adult Patients with Moderate to Severe Atopic Dermatitis

Not yet recruiting
2
220
Europe
DS107 Capsule, DS107G, Capsule, soft
DS Biopharma Ltd., DS Biopharma Ltd.
Moderate to Severe Atopic Dermatitis, Moderate to Severe Atopic Dermatitis, Diseases [C] - Skin and Connective Tissue Diseases [C17]
 
 
Galepa (daleuton topical) / DS Biopharma
No trials found
DS109 oral / DS Biopharma
No trials found
DS109 topical / DS Biopharma
No trials found

Download Options